Variant NM_000492.4:c.-8G>C
Name | NM_000492.4:c.-8G>C |
Protein name | NP_000483.3:p.(=) |
Genomic name (hg19) | chr7:g.117120141G>C UCSC |
#Exon/intron | UTR 5 |
Legacy Name | 125G/C |
Class | non disease-causing |
WT sequence | GGCCCTAGCAGGGACCCCAGCGCCC G AGAGACCATGCAGAGGTCGCCTCTG |
Mutant sequence | GGCCCTAGCAGGGACCCCAGCGCCC C AGAGACCATGCAGAGGTCGCCTCTG |
dbSNP rs1800501 |
Not found |
10 individuals carrying this variant are reported in CFTR-NGS catalogue |
TOTAL NUMBER OF PATIENTS | 65 |
---|---|
Asymptomatic compound heterozygote | 2 |
CF | 24 |
CFTR-RD | 34
|
Fetal bowel anomalies | 1 |
Pending | 1 |
Pending (NBS) | 2 |
Pending non-CF | 1 |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
Phenotype | Patient ID | Variant status | Additional variants |
---|---|---|---|
Other | 4582 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef |
Other | 4625 | heterozygote | VUS3 - Trans |
Other | 4315 | heterozygote | varying clinical consequence- Undef |
Other | 4292 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
Other | 5607 | heterozygote | VUS3- Undef |
Other | 2474 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef |
Other | 1184 | heterozygote | varying clinical consequence- Undef CFTR-RD-causing- Undef |
Other | 1123 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef |
Other | 5201 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
Other | 4695 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef |
CF | 3228 | heterozygote | CF-causing - Cis varying clinical consequence - Trans |
CF | 3223 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CF | 2975 | heterozygote | CF-causing - Cis CF-causing - Trans |
CF | 2974 | heterozygote | CF-causing - Cis CF-causing - Trans |
CF | 5067 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CF | 2828 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 4553 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 4231 | heterozygote | CF-causing - Cis CF-causing - Trans |
CF | 5341 | heterozygote | VUS3- Undef CF-causing- Undef |
CF | 652 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 637 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CF | 559 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CF | 373 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 316 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CF | 230 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 174 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 132 | heterozygote | CF-causing- Undef VUS3- Undef CF-causing- Undef |
CF | 4697 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 2241 | heterozygote | likely CF- Undef CF-causing- Undef |
CF | 1757 | heterozygote | CF-causing- Undef VUS3- Undef |
CF | 1516 | heterozygote | CF-causing- Undef VUS2- Undef |
CF | 1313 | heterozygote | likely CF- Undef |
CF | 1011 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 955 | heterozygote | CF-causing- Undef CF-causing- Undef |
CBAVD | 5068 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 4663 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
CBAVD | 3267 | heterozygote | VUS3- Undef CF-causing- Undef |
CBAVD | 4552 | heterozygote | CF-causing- Undef |
CBAVD | 5945 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 612 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
CBAVD | 401 | heterozygote | CF-causing- Undef |
CBAVD | 397 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
CBAVD | 396 | heterozygote | |
CBAVD | 4707 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
CBAVD | 746 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 2390 | heterozygote | CF-causing- Undef |
Pending non-CF | 753 | heterozygote | CF-causing- Undef VUS3- Undef |
Bronchiectasis | 3240 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
Bronchiectasis | 4242 | heterozygote | CF-causing- Undef |
Bronchiectasis | 2424 | heterozygote | |
Bronchiectasis | 2304 | heterozygote | CF-causing- Undef |
Pancreatitis | 3224 | heterozygote | VUS3- Undef CFTR-RD-causing- Undef VUS3- Undef |
Pancreatitis | 3016 | heterozygote | varying clinical consequence - Trans |
Pancreatitis | 4559 | heterozygote | CF-causing- Undef VUS3- Undef |
Pancreatitis | 4766 | heterozygote | VUS3- Undef |
Pancreatitis | 2418 | heterozygote | VUS3- Undef |
Pancreatitis | 2325 | heterozygote | CFTR-RD-causing- Undef |
Pancreatitis | 2324 | heterozygote | VUS3- Undef |
Fetal bowel anomalies | 2388 | heterozygote | CF-causing- Undef CF-causing- Undef |
Asymptomatic compound heterozygote | 3031 | heterozygote | varying clinical consequence - Cis CF-causing - Trans |
Asymptomatic compound heterozygote | 4656 | heterozygote | VUS3- Undef VUS3- Undef |
Pending (NBS) | 3042 | heterozygote | CF-causing - Cis varying clinical consequence - Trans |
Pending (NBS) | 5769 | heterozygote | CF-causing- Undef varying clinical consequence- Undef VUS3- Undef |
Pending | 3049 | heterozygote | CF-causing- Undef VUS3- Undef |
CRS-NP | 4276 | heterozygote | VUS3- Undef |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
CFTR variants are clustered into five groups: |
|